vs

Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $41.8M, roughly 1.3× Neuronetics, Inc.). Neuronetics, Inc. runs the higher net margin — -17.2% vs -24.7%, a 7.5% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -18.3%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -15.6%).

PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

MYPS vs STIM — Head-to-Head

Bigger by revenue
MYPS
MYPS
1.3× larger
MYPS
$55.4M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+104.0% gap
STIM
85.7%
-18.3%
MYPS
Higher net margin
STIM
STIM
7.5% more per $
STIM
-17.2%
-24.7%
MYPS
More free cash flow
MYPS
MYPS
$2.9M more FCF
MYPS
$3.6M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-15.6%
MYPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYPS
MYPS
STIM
STIM
Revenue
$55.4M
$41.8M
Net Profit
$-13.7M
$-7.2M
Gross Margin
52.0%
Operating Margin
-17.7%
-12.1%
Net Margin
-24.7%
-17.2%
Revenue YoY
-18.3%
85.7%
Net Profit YoY
38.9%
43.2%
EPS (diluted)
$-0.12
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYPS
MYPS
STIM
STIM
Q4 25
$55.4M
$41.8M
Q3 25
$57.6M
$37.3M
Q2 25
$59.3M
$38.1M
Q1 25
$62.7M
$32.0M
Q4 24
$67.8M
$22.5M
Q3 24
$71.2M
$18.5M
Q2 24
$72.6M
$16.4M
Q1 24
$77.8M
$17.4M
Net Profit
MYPS
MYPS
STIM
STIM
Q4 25
$-13.7M
$-7.2M
Q3 25
$-9.1M
$-9.0M
Q2 25
$-2.9M
$-10.1M
Q1 25
$-2.9M
$-12.7M
Q4 24
$-22.4M
$-12.7M
Q3 24
$-3.1M
$-13.3M
Q2 24
$-2.6M
$-9.8M
Q1 24
$-567.0K
$-7.9M
Gross Margin
MYPS
MYPS
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
MYPS
MYPS
STIM
STIM
Q4 25
-17.7%
-12.1%
Q3 25
-13.6%
-19.6%
Q2 25
-5.9%
-21.1%
Q1 25
-4.4%
-34.4%
Q4 24
-33.1%
-51.0%
Q3 24
-6.7%
-41.7%
Q2 24
-5.5%
-51.7%
Q1 24
-2.2%
-39.4%
Net Margin
MYPS
MYPS
STIM
STIM
Q4 25
-24.7%
-17.2%
Q3 25
-15.8%
-24.3%
Q2 25
-5.0%
-26.6%
Q1 25
-4.6%
-39.6%
Q4 24
-33.1%
-56.4%
Q3 24
-4.3%
-72.0%
Q2 24
-3.6%
-59.8%
Q1 24
-0.7%
-45.2%
EPS (diluted)
MYPS
MYPS
STIM
STIM
Q4 25
$-0.12
$-0.10
Q3 25
$-0.07
$-0.13
Q2 25
$-0.02
$-0.15
Q1 25
$-0.02
$-0.21
Q4 24
$-0.18
$-0.34
Q3 24
$-0.02
$-0.44
Q2 24
$-0.02
$-0.33
Q1 24
$0.00
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYPS
MYPS
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$104.9M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$227.9M
$22.4M
Total Assets
$290.6M
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYPS
MYPS
STIM
STIM
Q4 25
$104.9M
$28.1M
Q3 25
$106.3M
$28.0M
Q2 25
$112.9M
$11.0M
Q1 25
$107.1M
$20.2M
Q4 24
$109.2M
$18.5M
Q3 24
$105.2M
$20.9M
Q2 24
$106.3M
$42.6M
Q1 24
$127.0M
$47.7M
Total Debt
MYPS
MYPS
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
MYPS
MYPS
STIM
STIM
Q4 25
$227.9M
$22.4M
Q3 25
$238.9M
$27.4M
Q2 25
$245.3M
$27.1M
Q1 25
$244.1M
$35.5M
Q4 24
$244.7M
$27.7M
Q3 24
$265.2M
$9.4M
Q2 24
$263.6M
$19.4M
Q1 24
$288.4M
$27.7M
Total Assets
MYPS
MYPS
STIM
STIM
Q4 25
$290.6M
$141.6M
Q3 25
$299.2M
$145.5M
Q2 25
$316.2M
$134.7M
Q1 25
$313.8M
$142.0M
Q4 24
$323.0M
$140.9M
Q3 24
$330.6M
Q2 24
$333.4M
$96.8M
Q1 24
$357.5M
$103.8M
Debt / Equity
MYPS
MYPS
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYPS
MYPS
STIM
STIM
Operating Cash FlowLast quarter
$3.7M
$908.0K
Free Cash FlowOCF − Capex
$3.6M
$692.0K
FCF MarginFCF / Revenue
6.5%
1.7%
Capex IntensityCapex / Revenue
0.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.4M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYPS
MYPS
STIM
STIM
Q4 25
$3.7M
$908.0K
Q3 25
$5.7M
$-785.0K
Q2 25
$13.6M
$-3.5M
Q1 25
$3.3M
$-17.0M
Q4 24
$11.6M
$-8.6M
Q3 24
$14.6M
$-5.4M
Q2 24
$14.5M
$-5.0M
Q1 24
$5.0M
$-12.0M
Free Cash Flow
MYPS
MYPS
STIM
STIM
Q4 25
$3.6M
$692.0K
Q3 25
$5.4M
$-899.0K
Q2 25
$13.2M
$-3.8M
Q1 25
$3.2M
$-17.2M
Q4 24
$11.5M
$-8.7M
Q3 24
$13.9M
$-5.8M
Q2 24
$12.8M
$-5.6M
Q1 24
$3.6M
$-12.4M
FCF Margin
MYPS
MYPS
STIM
STIM
Q4 25
6.5%
1.7%
Q3 25
9.3%
-2.4%
Q2 25
22.3%
-9.9%
Q1 25
5.1%
-53.8%
Q4 24
16.9%
-38.6%
Q3 24
19.6%
-31.3%
Q2 24
17.6%
-34.0%
Q1 24
4.6%
-71.1%
Capex Intensity
MYPS
MYPS
STIM
STIM
Q4 25
0.2%
0.5%
Q3 25
0.5%
0.3%
Q2 25
0.7%
0.7%
Q1 25
0.2%
0.7%
Q4 24
0.2%
0.4%
Q3 24
0.9%
2.1%
Q2 24
2.4%
3.7%
Q1 24
1.9%
2.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons